EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 382 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $67,000 | -98.7% | 2,798 | -98.9% | 0.01% | -98.9% |
| Q4 2018 | $5,158,000 | +110.5% | 262,239 | +89.7% | 0.61% | +131.8% |
| Q3 2018 | $2,450,000 | -5.4% | 138,246 | +14.8% | 0.26% | -20.7% |
| Q2 2018 | $2,591,000 | +22.6% | 120,396 | +26.2% | 0.33% | +19.4% |
| Q1 2018 | $2,114,000 | +60.9% | 95,427 | +120.7% | 0.28% | +31.6% |
| Q4 2017 | $1,314,000 | – | 43,237 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |